$10 million for ADHD medicine on the PB
The Liberal National Government will invest $10 million to expand access to a medicine for attention deficit hyperactivity disorder (ADHD). Intuniv® (guanfacine) for the treatment of ADHD will be made available as an add-on therapy to other ADHD medicines on the Pharmaceutical Benefits Scheme (PBS) from March 1 this year. Without subsidy patients would…